Bioton S.a.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIO.WA research report →
About the company
Bioton S. A. operates as a biotechnology company, engaged in the creation, production, distribution, and commercialization of a diverse array of pharmaceuticals, medicinal preparations, and active pharmaceutical ingredients.
- CEO
- Jeremy Launders
- IPO
- 2005
- Employees
- 361
- HQ
- Ozarów Mazowiecki, PL
Price Chart
- Market Cap
- $329.29M
- P/E
- 81.25
- P/S
- 1.24
- P/B
- 0.56
- EV/EBITDA
- 8.00
- Div Yield
- 0.00%
- Gross Margin
- 35.79%
- Op Margin
- 5.22%
- Net Margin
- 1.52%
- ROE
- 0.69%
- ROIC
- 0.90%
- Revenue
- $282.52M · 35.98%
- Net Income
- $3.39M · 121.67%
- EPS
- $0.04 · 121.94%
- Op Income
- $12.81M
- FCF YoY
- -90.79%
- 52W High
- $4.70
- 52W Low
- $3.65
- 50D MA
- $4.15
- 200D MA
- $4.15
- Beta
- 0.17
- Avg Volume
- 42.32K
Get TickerSpark's AI analysis on BIO.WA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BIO.WA coverage
Recent articles, reports, and earnings notes.
No research on BIO.WA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIO.WA report →Similar companies
Peers in the same neighborhood.